A detailed history of Neuberger Berman Group LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,291 shares of AXNX stock, worth $304,575. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,291
Previous 4,409 2.68%
Holding current value
$304,575
Previous $296,000 0.68%
% of portfolio
0.0%
Previous 0.0%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$67.3 - $69.67 $7,941 - $8,221
-118 Reduced 2.68%
4,291 $298,000
Q2 2024

Nov 14, 2024

BUY
$66.47 - $69.65 $41,344 - $43,322
622 Added 16.42%
4,409 $296,000
Q2 2024

Aug 13, 2024

BUY
$66.47 - $69.65 $41,344 - $43,322
622 Added 16.42%
4,409 $296,000
Q1 2024

Nov 14, 2024

SELL
$56.67 - $69.36 $32.7 Million - $40 Million
-576,804 Reduced 99.35%
3,787 $261,000
Q1 2024

May 13, 2024

BUY
$56.67 - $69.36 $214,609 - $262,666
3,787 New
3,787 $261,000
Q4 2023

Nov 14, 2024

BUY
$49.38 - $63.75 $28.5 Million - $36.7 Million
576,182 Added 13068.31%
580,591 $36.1 Million
Q4 2023

Feb 09, 2024

BUY
$49.38 - $63.75 $2.27 Million - $2.93 Million
45,955 Added 8.6%
580,591 $36.1 Million
Q3 2023

Nov 14, 2023

SELL
$48.64 - $62.51 $6.71 Million - $8.62 Million
-137,898 Reduced 20.5%
534,636 $30 Million
Q2 2023

Aug 11, 2023

BUY
$47.99 - $60.21 $2.88 Million - $3.61 Million
60,014 Added 9.8%
672,534 $33.9 Million
Q1 2023

May 12, 2023

BUY
$52.6 - $67.34 $2.98 Million - $3.82 Million
56,733 Added 10.21%
612,520 $33.4 Million
Q4 2022

Feb 13, 2023

SELL
$59.56 - $76.6 $15.7 Million - $20.2 Million
-263,890 Reduced 32.19%
555,787 $34.8 Million
Q3 2022

Nov 15, 2022

SELL
$57.96 - $78.12 $369,263 - $497,702
-6,371 Reduced 0.77%
819,677 $57.8 Million
Q2 2022

Aug 15, 2022

BUY
$39.5 - $64.42 $4.39 Million - $7.16 Million
111,201 Added 15.56%
826,048 $46.9 Million
Q1 2022

May 23, 2022

BUY
$43.74 - $62.76 $30,355 - $43,555
694 Added 0.1%
714,847 $44.8 Million
Q1 2022

May 13, 2022

BUY
$43.74 - $62.76 $5.58 Million - $8 Million
127,478 Added 21.73%
714,153 $43.9 Million
Q4 2021

Feb 11, 2022

BUY
$50.01 - $73.35 $17.9 Million - $26.3 Million
358,842 Added 157.5%
586,675 $32.3 Million
Q3 2021

Nov 12, 2021

BUY
$59.21 - $78.66 $257,030 - $341,463
4,341 Added 1.94%
227,833 $14.1 Million
Q2 2021

Aug 13, 2021

BUY
$51.39 - $66.9 $380,234 - $494,993
7,399 Added 3.42%
223,492 $13.7 Million
Q1 2021

May 13, 2021

BUY
$49.14 - $59.89 $3.98 Million - $4.85 Million
80,903 Added 59.84%
216,093 $12.6 Million
Q4 2020

Feb 10, 2021

SELL
$42.19 - $51.5 $19,913 - $24,308
-472 Reduced 0.35%
135,190 $6.62 Million
Q3 2020

Nov 12, 2020

BUY
$35.33 - $51.04 $1.52 Million - $2.19 Million
42,962 Added 46.35%
135,662 $6.92 Million
Q2 2020

Aug 13, 2020

BUY
$22.91 - $39.83 $1.15 Million - $1.99 Million
50,000 Added 117.1%
92,700 $3.26 Million
Q1 2020

May 14, 2020

SELL
$16.44 - $37.73 $287,700 - $660,275
-17,500 Reduced 29.07%
42,700 $1.09 Million
Q4 2019

Feb 12, 2020

BUY
$19.57 - $28.96 $1.18 Million - $1.74 Million
60,200 New
60,200 $1.67 Million

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Neuberger Berman Group LLC Portfolio

Follow Neuberger Berman Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.